
Genetic manipulation of B cells for the isolation of rare therapeutic antibodies from the human repertoire
Keywords: AID; activation-induced cytidine deaminase; BCL-6; B cell lymphoma-6; Bcl-xL; B-cell lymphoma-extra large; BCR; B-cell receptor; EBV; Epstein-Barr virus; GALV; gibbon ape leukemia virus; IRES; internal ribosomal entry sequence; MMLV; moloney murine leukem